>

Gilead Halevy - COMPUGEN Director

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>CO</div>
CGEN -- Israel Stock  

ILA 2,520  234.00  8.50%

  Director
Mr. Gilead Halevy was appointed Director at Compugen Ltd. effective June 11, 2018. His work experience includes the following roles Chairman of the Board of Brand Industries Ltd., Carmor Integrated Solutions Ltd., Carmel Wineries, Continuity Software Ltd. and S.AL Holdings., Founding Member and General Partner of Kedma Capital Partners and Head of Giza VCs European business activities 920012006
Age: 51  Director Since 2018      
(972) 3 765 8555  www.cgen.com
Halevy holds a Bachelors degree in Humanities and a LLB degree, both from The Hebrew University of Jerusalem.

Management Efficiency

The company has return on total asset (ROA) of (0.01) % which means that it has lost $0.01 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (0.84) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 4.94 M in total debt with debt to equity ratio (D/E) of 14.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. COMPUGEN has Current Ratio of 7.05 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Guy BenDrorARAD LTD
2009
Irit TobiasDELEK AUTOMOTIVE S
2018
Saul YemalMEDTECHNICA
2012
Uri MeitalARAD LTD
2019
Asaf BartfeldDELEK AUTOMOTIVE S
1992
Shacham MittlerARAD LTD
2010
Malka DorDELEK AUTOMOTIVE S
2011
Jacob OrbachDELEK AUTOMOTIVE S
2019
Aric CohenARAD LTD
2017
Tal YaronEldarMEDTECHNICA
2012
Tamar GaliliMEDTECHNICA
2011
Reuven LevinMEDTECHNICA
N/A
Ronny BarnirARAD LTD
2016
Ephraim AbramsonARAD LTD
2017
Dror PazARAD LTD
2014
Daniel VakninARAD LTD
2017
Ofer ZellermayerDELEK AUTOMOTIVE S
2009
Tova PintoARAD LTD
2011
Rony BrenerARAD LTD
2010
Shmuel LeshemARAD LTD
2019
Israel TchetchikDELEK AUTOMOTIVE S
2013

Company Summary

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 89 people.COMPUGEN (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 89 people.

COMPUGEN Leadership Team

Joshua Shemer, Independent External DirectorView
Michal Preminger, DirectorView
Paul Sekhri, Chairman of the BoardView
Dov Hershberg, DirectorView
Martin Gerstel, Chairman of the BoardView
Arie Ovadia, Independent External DirectorView
Zurit Levine, Vice President - Research and DiscoveryView
Eran Perry, DirectorView
Ari Krashin, Chief Financial OfficerView
Sanford Zweifach, DirectorView
Gilead Halevy, DirectorView
Anat CohenDayag, President, Chief Executive Officer, DirectorView
Ruth Arnon, Independent DirectorView
Kinneret Savitsky, DirectorView
Henry Adewoye, Chief Medical OfficerView
Yair Aharonowitz, Independent External DirectorView
JeanPierre Bizzari, DirectorView
John Hunter, VP of Antibody RandD and Site Head of Compugen USA IncView

Stock Performance Indicators

Current Sentiment - CGEN

COMPUGEN Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in COMPUGEN. What is your opinion about investing in COMPUGEN? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

COMPUGEN Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for COMPUGEN and CIM COMMERICAL TRU. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page